Lagumbay, Arnie T.

HRN: 22-96-63  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2023
CEFUROXIME 1.5GM (VIAL)
04/28/2023
04/28/2023
IV
1.5grams
Q8hrs
UTI; Pus Cells: 15-20; Bacteria: Abundant; Epithelial: Abundant
Checking Final Appropriateness 
04/30/2023
CEFUROXIME 500MG (TAB)
04/30/2023
05/07/2023
PO
500mg
Bid
Uti
Waiting Final Action 
05/14/2023
CEFUROXIME 1.5GM (VIAL)
05/14/2023
05/17/2023
IV
1.5 Grams
Now
Stat CS
Waiting Final Action 
05/14/2023
CEFUROXIME 1.5GM (VIAL)
05/14/2023
05/15/2023
IV
1.5gram
Q 8hrs X 3 Doses
Primary LTCS
Waiting Final Action 
05/15/2023
CEFUROXIME 500MG (TAB)
05/15/2023
05/22/2023
PO
500mg
BID
S/P Primary LSTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: